Inhibition of DPP-4 with vildagliptin improved insulin secretion in response to oral as well as "isoglycaemic" glucose without numerically changing the incretin effect in patients with type 2 diabetes

被引：0
|
作者：
Foley, J. E. [1 ]
Becker, L. [2 ]
Koethe, L. [2 ]
Dejager, S. [3 ]
Schweizer, A. [4 ]
Nauck, M. A. [2 ]
机构：
[1] Novartis, E Hanover, NJ USA
[2] Diabet Zentrum, Bad Lauterberg Im Harz, Germany
[3] Novartis, Paris, France
[4] Novartis, Basel, Switzerland
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
917
引用
收藏
页码：S367 / S367
页数：1
相关论文
共 50 条
  • [11] Safety proile of the DPP-4 inhibitors vildagliptin and sitagliptin in patients with type 2 diabetes and severe renal impairment
    Lukashevich, V.
    Foley, J.
    Schweizer, A.
    Rendell, M. S.
    Kothny, W.
    DIABETOLOGIA, 2014, 57 : S362 - S362
  • [12] The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
    Choe, Eun Yeong
    Cho, Yongin
    Choi, Younjeong
    Yun, Yujung
    Wang, Hye Jin
    Kwon, Obin
    Lee, Byung-Wan
    Ahn, Chul Woo
    Cha, Bong Soo
    Lee, Hyun Chul
    Kang, Eun Seok
    DIABETES & METABOLISM JOURNAL, 2014, 38 (03) : 211 - 219
  • [13] Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors
    Mathieu, C.
    Bollaerts, K.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 : 29 - 37
  • [14] The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes
    Luzio, S. D.
    Dunseath, G.
    Lockett, A.
    Broke-Smith, T. P.
    New, R. R.
    Owens, D. R.
    DIABETES OBESITY & METABOLISM, 2010, 12 (01): : 82 - 87
  • [15] Differential effects of DPP-4 inhibition on incretin hormone levels in drug-naive and metformin-treated patients with type 2 diabetes
    Dunning, B. E.
    Ligueros-Saylan, M.
    D'Alessio, D. A.
    Balas, B.
    Kelley, D. E.
    Deacon, C. F.
    Holst, J. J.
    Foley, J. E.
    DIABETOLOGIA, 2006, 49 : 110 - 111
  • [16] Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes
    Cuthbertson, J.
    Patterson, S.
    O'Harte, F. P. M.
    Bell, P. M.
    DIABETIC MEDICINE, 2009, 26 (06) : 649 - 654
  • [17] The efficacy of therapy with DPP-4 inhibitors combined with insulin in patients with type 2 diabetes mellitus
    Ametov, A. S.
    Karpova, E., V
    DIABETES MELLITUS, 2011, 14 (04): : 55 - 59
  • [18] The capability increase the incretin effect in response to increasing oral glucose loads is impaired in patients with type 2 diabetes
    Bagger, J. O.
    Knop, F. K.
    Lund, A.
    Vestergaard, H.
    Holst, J. J.
    Vilsboll, T.
    DIABETOLOGIA, 2009, 52 : S228 - S228
  • [19] Effectiveness of DPP-4 Inhibitors on Blood Glucose Variability in Type 2 Diabetes Patients Undergoing Hemodialysis
    Ishikawa, Tomomi
    Hosojima, Michihiro
    Kabasawa, Hideyuki
    Kaseda, Ryohei
    Kuwahara, Shoji
    Iino, Noriaki
    Tanaka, Takahiro
    Kitamura, Nobutaka
    Suzuki, Yoshiki
    Narita, Ichiei
    Saito, Akihiko
    DIABETES, 2017, 66 : LB29 - LB29
  • [20] Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus
    Kothny, W.
    Foley, J.
    Kozlovski, P.
    Shao, Q.
    Gallwitz, B.
    Lukashevich, V.
    DIABETES OBESITY & METABOLISM, 2013, 15 (03): : 252 - 257
12345